Sunmax Biotechnology Co Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sunmax Biotechnology Co Limited with three other
companies in this sector in Taiwan:
Obi Pharma Inc
sales of 92.42 million Taiwanese Dollars [US$3.06 million]
of which 100%
was Division 1),
Taigen Biopharmaceuticals Holdings Ltd
(146.02 million Taiwanese Dollars [US$4.84 million]
of which 90%
was Medical Development), and
Tpg Biologics Inc
(48.22 million Taiwanese Dollars [US$1.60 million]
Sunmax Biotechnology Co Limited reported sales of 155.53 million Taiwanese Dollars (US$5.15 million)
December of 2016.
increase of 39.3%
versus 2015, when the company's sales were 111.65 million Taiwanese Dollars.
Despite this increase, sales are still
below the level achieved in 2014, when Sunmax Biotechnology Co Limited
reported sales of 183.88 million Taiwanese Dollars.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Sunmax Biotechnology Co Limited had sales
of 146.62 million Taiwanese Dollars.